Research for Acute Myeloid Leukaemia and Follicular Lymphoma
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Recruiting
Observational Study
Acute Myeloid Leukaemia (AML)
Follicular Lymphoma ( FL)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 550 (estimated)
- Sponsor
- Tempus AI · Industry
Who this trial is looking for
This trial is looking for patients diagnosed with Acute Myeloid Leukaemia or Follicular Lymphoma. Participants will provide blood samples and leftover tissue during routine treatment to help study their conditions over time.
Are You a Good Fit for This Trial?
You may be able to join if
- I am willing to participate and provide blood samples.
- I can give informed consent.
- I have been diagnosed with Acute Myeloid Leukaemia.
- I have been diagnosed with Follicular Lymphoma.
You may not be able to join if
- I cannot follow the study procedures.
- I have received prior standard therapy for Acute Myeloid Leukaemia.
- I have received prior treatment for Follicular Lymphoma.
- I am diagnosed with High Risk Follicular Lymphoma.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the associat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
All Cohorts Inclusion Criteria:
1. Willing and able to participate in the research and provide biospecimens
2. Willing and able to provide informed consent
Cohort 001 Inclusion:
1. Have documented diagnosis of AML according to the World Health Organization (WHO) classification
2. Secondary AML is…
Contacts